Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05276934
Other study ID # SRB2021298
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 1, 2022
Est. completion date December 20, 2025

Study information

Verified date February 2024
Source Erasme University Hospital
Contact Comite ethique hopital Erasme
Phone 003225553707
Email comite.ethique@erasme.ulb.ac.be
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study is an observational prospective evaluation of an approved and unchanged clinical management, evaluating different diagnosis methods to assess brain perfusion in patients with an aneurysmal or AVM-related intracranial hemorrhage


Description:

The study is a prospective description and evaluation of an approved and unchanged clinical management, evaluating already used different diagnosis methods to assess brain perfusion in patients with atraumatic (aneurysmal, AVM-related, unknown cause) intracranial hemorrhage.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 20, 2025
Est. primary completion date October 20, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 100 Years
Eligibility i. Inclusion Criteria 1. Age = 18 years 2. Non-traumatic intracranial hemorrhage (subarachnoid hemorrhage secondary to a ruptured aneurysm or AVM, unknown cause, per procedural bleed) 3. In case of ruptured aneurysm, AVM or other etiology : need to be secured with surgical clipping or endovascular intervention if judged possible 4. No contra-indication to perfusion imaging 5. Subject or legal representative is able and willing to give informed consent. ii. Exclusion Criteria 1. Traumatic intracranial hemorrhage 2. Contra-indication to imaging or patient's refusal.

Study Design


Intervention

Diagnostic Test:
Brain computed tomography
This study will use an established local protocol for DCI and intracranial arterial vasospastic stenosis screening, and follow-up to make sure that all patients have the same protocol and don't lose any chance of improvement and good outcome : CT perfusion at different time intervals

Locations

Country Name City State
Belgium Erasme Hospital Brussel

Sponsors (1)

Lead Sponsor Collaborator
Erasme University Hospital

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in brain hypoperfusion Brain hypoperfusion in arterial territories assessed by the delays on perfusion Time to drain (seconds) on CT and/or MR perfusion Change between day 0, 5, 9 after Intracranial Hemorrhage
Secondary Change in vessel size Change in the vessel size measured on digital subtraction angiography (DSA) and computed tomography angiogram (CTA) in millimeters Change between day 0, 5, 9 after Intracranial Hemorrhage
Secondary Time to next endovascular intervention for vasospastic stenosis Delay between two procedures for the same indication Number of days after the endovascular procedure until the next procedure in days, up to 4 weeks
Secondary Transcranial Doppler Reduction in intracranial vasospasm assessed by the targeted vessel velocity in meters per second Change between day 0, 5, 9 after Intracranial Hemorrhage
Secondary Brain Hypoperfusion 2 Reduction in brain hypoperfusion assessed by the volumes on different perfusion parameters time to peak (in seconds) on CT and/or MR perfusion Change between day 0, 5, 9 after Intracranial Hemorrhage
Secondary Change in Glasgow coma scale Glasgow coma scale (GCS between 3 and 15, a higher score means a better outcome) Change between day 0, 5, 9 after Intracranial Hemorrhage
Secondary Change in National Institutes of Health Stroke Scale score National Institutes of Health Stroke Scale (NIHSS between 0 and 42, a higher score means a worse outcome) Change between day 0, 5, 9 after Intracranial Hemorrhage
Secondary Change in the monitoring of tissue oxygen pressure (PtiO2) Monitoring of tissue oxygen pressure (PtiO2) Change between day 0, 5, 9 after Intracranial Hemorrhage
Secondary Change in the number of new ischemic lesions Number of new ischemic lesions on non-contrast CT scan Change between day 0, 5, 9, 21 after Intracranial Hemorrhage
Secondary modified Rankin Scale at 3 months clinical evolution (mRS between 0 and 6, a higher score means a worse outcome) 3 months after Intracranial Hemorrhage
Secondary Change in brain hypoperfusion 3 Brain hypoperfusion in arterial territories assessed by the delays on perfusion parameters TMax maps in seconds on CT and/or MR perfusion Change between day 0, 5, 9 after Intracranial Hemorrhage
Secondary Change in brain hypoperfusion 4 Brain hypoperfusion in arterial territories assessed by the delays on perfusion parameters Mean transit time on CT and/or MR perfusion in seconds Change between day 0, 5, 9 after Intracranial Hemorrhage
See also
  Status Clinical Trial Phase
Recruiting NCT04870047 - Coating to Optimize Aneurysm Treatment In The New Flow Diverter Generation N/A
Recruiting NCT05968053 - Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
Not yet recruiting NCT05665309 - Interest of Pre-operative Use of 3D Printing for Endovascular Treatment of Unruptured Intracranial Aneurysms With Intrasaccular Flow Disruptor N/A
Completed NCT02783339 - Neuroform Atlas Stent for Intracranial Aneurysm Treatment
Withdrawn NCT01194388 - Axium Coil in Completing Endovascular Aneurysm Surgery Study
Completed NCT00071565 - Familial Intracranial Aneurysm Study II N/A
Recruiting NCT05409989 - MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study N/A
Completed NCT03680742 - Contour Neurovascular System - European Pre-Market Unruptured Aneurysm N/A
Completed NCT04872842 - Establishment of Online Registration Platform for Unruptured Intracranial Aneurysms Based on 100 Regional Medical Centers in China and Population Follow-up Study
Terminated NCT02532517 - Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device N/A
Completed NCT03663257 - Study to Evaluate Cerebral AneurysmFlow Results in Occlusion
Recruiting NCT06189950 - Registration Trial of the Intracranial Visualized Stent for the Wide-necked Intracranial Aneurysms:REBRIDGE N/A
Recruiting NCT05608122 - Establishment of Online Registration Platform for Unruptured Intracranial Aneurysms Based on Regional Medical Centers in China and Population Follow-up Study (Phase Ⅱ)
Recruiting NCT03661463 - Unruptured Intracranial Aneurysm Aspirin Trial (UIAAT). Phase 2
Completed NCT02609867 - A Feasibility Study to Evaluate the Safety and Effectiveness of Implantation of Flowise Cerebral Flow Diverter (Flowise) N/A
Active, not recruiting NCT02292017 - Prospective Packing Density With Target Coils I N/A
Active, not recruiting NCT01872741 - Minipterional Versus Pterional Craniotomy N/A
Completed NCT00993057 - Efficiency of Two Glucose Sampling Protocols for Maintenance of Euglycemia Early Phase 1
Completed NCT00777907 - Complete Occlusion of Coilable Aneurysms Phase 3
Completed NCT00777088 - Pipeline for Uncoilable or Failed Aneurysms N/A